Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W. David Nassif

Affiliations

  • Principal Financial Officer at Axovant Gene Therapies Ltd. (AXGT), 2019-09-24
  • Evp And Cfo at Steadymed Ltd. (STDY), 2018-09-04
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
STDY $4.46 22,157 Officer 0 2018-08-30 Filing
STDY $4.50 12,157 22,157 2018-07-05 Filing
STDY $4.50 10,001 Officer 34,314 2018-07-02 Filing